We are pleased to formally announce the establishment of a strategic partnership between UniPrisma Venture Studio and PMK Group (CRU Global Network). 

UniPrisma Venture Studio is a new venture studio born from years of experience at the intersection of academia and entrepreneurship.

With deep roots in Central and Eastern Europe, it’s designed to turn untapped university innovation into the next generation of healthcare and life science success stories.

PMK Group, recognized globally for its clinical execution excellence and strategic investments, specializes in supporting Biotech and MedTech ventures through rigorous clinical trial management and strategic growth initiatives.

This collaboration uniquely integrates the strengths of both organizations:

➡️ Early-stage Innovation Identification
Utilizing UniPrisma’s extensive university network to identify promising research opportunities early in their development.

➡️ Clinical Development Expertise
Leveraging PMK-Group’s proven experience in managing over 350 successful clinical trials significantly enhances the probability of successful clinical outcomes.

➡️ Investment and Co-Investment Strategies
Offering comprehensive financial support and structured investment options to facilitate the progression of early-stage research to clinical-stage readiness.

➡️ Comprehensive Market Access
Providing specialized regulatory and market entry support, enabling effective commercialization across Europe, Asia-Pacific, and the US.

Our shared goal is to seamlessly transition scientific discoveries from academia to impactful commercial applications, reducing risk and fostering sustainable growth within the Biotech and MedTech sectors.

We look forward to a fruitful collaboration to advance healthcare and life sciences innovations globally.

Written by: Dr. Peter M. Kovacs